Overview

Prevention of Restenosis Following Revascularization

Status:
Terminated
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the prevention of Restenosis following Revascularization of the superficial Femoral Artery (SFA)
Phase:
Phase 2
Details
Lead Sponsor:
Celgene Corporation
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel
Polystyrene sulfonic acid